People · Operator

Tom Raffin, M.D.

Named in public records as an officer, director or promoter · active 2008–2009 · Biotechnology

1
Companies
2
Filings
$67.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Newlink Genetics CorpBiotechnologySeries B$67.5M$411.2M2008
Operator network

Tom Raffin, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Paul R. Edick · 2 companies · 1 sharedPaul R. EdickCharles Link, M.D. · 1 companies · 1 sharedCharles Link, M.D.David J. Lundquist · 1 companies · 1 sharedDavid J. LundquistErnest H. Talarico, III · 1 companies · 1 sharedErnest H. Talaric…Ernest Talarico, III · 1 companies · 1 sharedErnest Talarico, …Gordon H. Link · 1 companies · 1 sharedGordon H. LinkJoseph J. Saluri · 1 companies · 1 sharedJoseph J. SaluriKenneth J. Lynn · 1 companies · 1 sharedKenneth J. LynnKenneth Lynn · 1 companies · 1 sharedKenneth LynnNicholas Vahanian, M.D. · 1 companies · 1 sharedNicholas Vahanian…Paul J. Edick · 1 companies · 1 sharedPaul J. EdickSarah J. Alexander, M.D. · 1 companies · 1 sharedSarah J. Alexande…Tom H. Raffin, M.D. · 1 companies · 1 sharedTom H. Raffin, M.…Newlink Genetics Corp · $67.5M raisedNewlink Genetics CorpTom Raffin, M.D.TM
Tom Raffin, M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Tom Raffin, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Paul R. Edick12
Ernest H. Talarico, III11
Joseph J. Saluri11
Nicholas Vahanian, M.D.11
Kenneth J. Lynn11
Gordon H. Link11
David J. Lundquist11
Sarah J. Alexander, M.D.11
Tom H. Raffin, M.D.11
Charles Link, M.D.11
Paul J. Edick11
Kenneth Lynn11
Ernest Talarico, III11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.